{"meta":{"totalResults":1,"from":0},"results":[{"aliases":[{"type":"USBrandName","name":"Inderal"},{"type":"ObsoleteName","name":"Innopran XL"},{"type":"USBrandName","name":"Hemangeol"},{"type":"ChemicalStructureName","name":"2-propanol-1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy) hydrochloride"},{"type":"NSCNumber","name":"91523"},{"type":"CASRegistryName","name":"318-98-9"}],"definition":{"html":"The hydrochloride form of propranolol, a synthetic beta-adrenergic receptor blocker with antianginal, antiarrhythmic, and antihypertensive properties. Propranolol competitively antagonizes beta-adrenergic receptors, thereby inhibiting beta-adrenergic reactions, such as vasodilation, and negative chronotropic and inotropic effects.","text":"The hydrochloride form of propranolol, a synthetic beta-adrenergic receptor blocker with antianginal, antiarrhythmic, and antihypertensive properties. Propranolol competitively antagonizes beta-adrenergic receptors, thereby inhibiting beta-adrenergic reactions, such as vasodilation, and negative chronotropic and inotropic effects."},"drugInfoSummaryLink":{"uri":"https://www.cancer.gov/about-cancer/treatment/drugs/propranolol-hydrochloride","text":"Propranolol Hydrochloride"},"nciConceptId":"C29382","nciConceptName":"Propranolol Hydrochloride","termId":561498,"name":"propranolol hydrochloride","firstLetter":"p","type":"DrugTerm","termNameType":"PreferredName","prettyUrlName":"propranolol-hydrochloride"}],"links":null}